The biology of natural killer cells in cancer, infection, and pregnancy

被引:88
作者
Miller, JS [1 ]
机构
[1] Univ Minnesota, Ctr Canc, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA
关键词
D O I
10.1016/S0301-472X(01)00696-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. NK cells are important cells of the immune system. They are ultimately derived from pluripotent hematopoietic stem cells. NK cell cytotoxicity and other functions are tightly regulated by numerous activating and inhibitory receptors including newly discovered receptors that selectively recognize major histocompatibility complex class I alleles. Based on their defining function of spontaneous cytotoxicity without prior immunization, NK cells have been thought to play a critical role in immune surveillance and cancer therapy. However, new insights into NK cell biology have suggested major roles for NK cells in infection control and uterine function. The purpose of this review is to provide an update on NK cell function, ontogeny, and biology in order to better understand the role of NK cells in health and disease. Data Sources. In the Medline database, the major subject heading "Natural Killer Cells" was introduced in 1983, identifying 16,848 citations as of December 31, 2000. Since 1986, there have been approximately 1000 citations per year under this subject heading. In this database, 68% of manuscripts are limited to human NK cells; 40% of citations cross with the major subheading of cytotoxicity, 40% with cytokines, 36% with neoplasm, 5% with antibody-dependent cellular cytotoxicity, 2.8% with pregnancy, and 1.3% with infection. Of references from the year 2000-2001, 46 were selected to combine with contributions from earlier literature. Conclusions. NK cells should no longer be thought of as direct cytotoxic killers alone as they clearly serve a critical role in cytokine production which may:be important to control cancer, infection, and fetal implantation. Understanding mechanisms of NK cell functions may lead to novel therapeutic strategies for the treatment of human disease. (C) 2001 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:1157 / 1168
页数:12
相关论文
共 151 条
[101]  
Nakajima H, 2000, BLOOD, V96, p145A
[102]   Requirement for IRF-1 in the microenvironment supporting development of natural killer cells [J].
Ogasawara, K ;
Hida, S ;
Azimi, N ;
Tagaya, Y ;
Sato, T ;
Yokochi-Fukuda, T ;
Waldmann, TA ;
Taniguchi, T ;
Taki, S .
NATURE, 1998, 391 (6668) :700-703
[103]  
OKUNEWICK JP, 1995, BONE MARROW TRANSPL, V16, P451
[104]  
Orange JS, 1996, J IMMUNOL, V156, P1138
[105]   REQUIREMENT FOR NATURAL-KILLER CELL-PRODUCED INTERFERON-GAMMA IN DEFENSE AGAINST MURINE CYTOMEGALOVIRUS-INFECTION AND ENHANCEMENT OF THIS DEFENSE PATHWAY BY INTERLEUKIN-12 ADMINISTRATION [J].
ORANGE, JS ;
WANG, BP ;
TERHORST, C ;
BIRON, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :1045-1056
[106]   X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells [J].
Parolini, S ;
Bottino, C ;
Falco, M ;
Augugliaro, R ;
Giliani, S ;
Franceschini, R ;
Ochs, HD ;
Wolf, H ;
Bonnefoy, JY ;
Biassoni, R ;
Moretta, L ;
Notarangelo, LD ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (03) :337-346
[107]   Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells [J].
Pende, D ;
Parolini, S ;
Pessino, A ;
Sivori, S ;
Augugliaro, R ;
Morelli, L ;
Marcenaro, E ;
Accame, L ;
Malaspina, A ;
Biassoni, R ;
Bottino, C ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1505-1516
[108]   Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity [J].
Pessino, A ;
Sivori, S ;
Bottino, C ;
Malaspina, A ;
Morelli, L ;
Moretta, L ;
Biassoni, R ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :953-960
[109]   CD56(+bright) and CD56(+dim) natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis [J].
Pierson, BA ;
Miller, JS .
BLOOD, 1996, 88 (06) :2279-2287
[110]   Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor [J].
Ponte, M ;
Cantoni, C ;
Biassoni, R ;
Tradori-Cappai, A ;
Bentivoglio, G ;
Vitale, C ;
Bertone, S ;
Moretta, A ;
Moretta, L ;
Mingari, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5674-5679